Skip to main content

Genenta Science S.p.A.

GNTA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001838716

No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Genenta Science S.p.A. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
9
−2 vs. Q1 2026
Shares held
720.7K
−314.7K (−30.4%) vs. Q1 2026
Total value
$1.33M
+$630.5K (+90.6%) vs. Q1 2026
New holders
2
1 more added
Sold out
4
3 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 9 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 2 institutionsQ1 2022: 3 institutionsQ2 2022: 3 institutionsQ3 2022: 2 institutionsQ4 2022: 4 institutionsQ1 2023: 2 institutionsQ2 2023: 4 institutionsQ3 2023: 3 institutionsQ4 2023: 4 institutionsQ1 2024: 5 institutionsQ2 2024: 5 institutionsQ3 2024: 5 institutionsQ4 2024: 4 institutionsQ1 2025: 5 institutionsQ2 2025: 5 institutionsQ3 2025: 6 institutionsQ4 2025: 15 institutionsQ1 2026: 11 institutionsQ2 2026: 9 institutions
Value heldQ2 2026: $1.33M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $517.0KQ1 2022: $332.0KQ2 2022: $27.0KQ3 2022: $17.0KQ4 2022: $264.4KQ1 2023: $273.8KQ2 2023: $2.73MQ3 2023: $2.29MQ4 2023: $3.67MQ1 2024: $2.07MQ2 2024: $1.04MQ3 2024: $1.48MQ4 2024: $1.42MQ1 2025: $2.10MQ2 2025: $1.82MQ3 2025: $1.77MQ4 2025: $4.04MQ1 2026: $695.7KQ2 2026: $1.33M
Institutions holding GNTA and their total value by quarter
QuarterHoldersValue
Q2 20269$1.33M
Q1 202611$695.7K
Q4 202515$4.04M
Q3 20256$1.77M
Q2 20255$1.82M
Q1 20255$2.10M
Q4 20244$1.42M
Q3 20245$1.48M
Q2 20245$1.04M
Q1 20245$2.07M
Q4 20234$3.67M
Q3 20233$2.29M
Q2 20234$2.73M
Q1 20232$273.8K
Q4 20224$264.4K
Q3 20222$17.0K
Q2 20223$27.0K
Q1 20223$332.0K
Q4 20212$517.0K
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Genenta Science S.p.A.; share changes are against Q1 2026.

Institutions holding GNTA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Eurizon Capital SGR S.p.A.360,000$662.4K0.00%00.0%Unchanged
Allianz SE234,050$430.7K0.00%00.0%Unchanged
SmartHarvest Portfolios, LLC43,856$80.7K0.03%−90,591−67.4%Reduced
Virtu Financial LLC36,913$68.0K0.00%+36,913New
Simplicity Wealth,LLC18,590$34.2K0.00%+6,379+52.2%Added
Ground Swell Capital, LLC14,374$26.4K0.03%+14,374New
GAMMA Investing LLC9,863$18.1K0.00%−4,425−31.0%Reduced
UBS Group AG3,027$5.57K0.00%−80−2.6%Reduced
Farther Finance Advisors, LLC3$60.00%00.0%Unchanged
AlTi Global, Inc.0$00.00%−200,288−100.0%Sold out
Independent Advisor Alliance0$00.00%−37,036−100.0%Sold out
XTX Topco Ltd0$00.00%−24,527−100.0%Sold out
Morgan Stanley0$00.00%−15,420−100.0%Sold out